KELONIA THERAPEUTICS
Kelonia Therapeutics is developing a new wave of genetic medicines using its next generation vivo gene delivery platform.
KELONIA THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.keloniatx.com
Total Employee:
11+
Status:
Active
Total Funding:
50 M USD
Current Employees Featured
Gabi Ndakwah
Gabi Ndakwah Associate Scientist I @ Kelonia Therapeutics Associate Scientist I
Denise Wong
Denise Wong Senior Associate Scientist II @ Kelonia Therapeutics Senior Associate Scientist II
Josue Figueroa
Josue Figueroa Principal Associate Scientist @ Kelonia Therapeutics Principal Associate Scientist
Howie Latimer
Howie Latimer Principal Associate Scientist @ Kelonia Therapeutics Principal Associate Scientist
Molly Perkins
Molly Perkins Vice President of Research @ Kelonia Therapeutics Vice President of Research
Jennifer Curry
Jennifer Curry Vice President, HR @ Kelonia Therapeutics Vice President, HR
Shirley Dong
Shirley Dong Associate Scientist II @ Kelonia Therapeutics Associate Scientist II
Shannon Grande Contrastano
Shannon Grande Contrastano Senior Director, Preclinical Sciences @ Kelonia Therapeutics Senior Director, Preclinical Sciences
Kaiysa Mendy
Kaiysa Mendy Office Manager/HR Coordinator @ Kelonia Therapeutics Office Manager/HR Coordinator
Kevin Friedman
Kevin Friedman Chief Scientific Officer, President @ Kelonia Therapeutics Chief Scientific Officer, President
Investors List
Alta Partners
Alta Partners investment in Series A - Kelonia Therapeutics
Venrock
Venrock investment in Series A - Kelonia Therapeutics
Horizons Ventures
Horizons Ventures investment in Series A - Kelonia Therapeutics
Official Site Inspections
http://www.keloniatx.com Semrush global rank: 5 M Semrush visits lastest month: 1.68 K
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ...